pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3940 |
Genomic Coordinates | chr19: 6416410 - 6416511 |
Description | Homo sapiens miR-3940 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3940-3p | |||||||||||||||||||||||||||||||||
Sequence | 57| CAGCCCGGAUCCCAGCCCACUU |78 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PPP1R11 | ||||||||||||||||||||
Synonyms | CFAP255, HCG-V, HCGV, IPP3, TCTE5, TCTEX5 | ||||||||||||||||||||
Description | protein phosphatase 1 regulatory inhibitor subunit 11 | ||||||||||||||||||||
Transcript | NM_021959 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PPP1R11 | |||||||||||||||||||||
3'UTR of PPP1R11 (miRNA target sites are highlighted) |
>PPP1R11|NM_021959|3'UTR 1 ATCCCTCTCTCCTCCAGCATTCCTGTGTCTGTCTGGCCCTAAATGTATCCATGTGGCTACTTCTCCAGCCCCCTCCTTCC 81 CTCTCTTCTGCCTGATAGAGGGAAGAGGAAGAGGAGGACGAACAGAGATCCTGAAATTCTGACTTGCTGCTATTCCAGAA 161 CCCAGCCTCCTGGGTTTCCCCAGTCCTCATTTTTCCTCCCAATACCCACCCTTCTCTCTCGAGGGATCTAGGCACCTTGG 241 TCCCAGTGTCTTCCTTTTGTTCTCACTGCCAAACTGCCTGTCCTGGGATCTAGTTATCTTGGCCCTGCACTCTCAACATG 321 AGTAGCGAACACTTAAATTGGGTTTTCAACAGTCCCAGCTTTCACTGCCAGGGTCCCAGTCAGATTCCAGGAATTTGCGC 401 CCTAACTTTGCTTGCTAATCCTGGTTTAGAGCTATCCCACTAAAATATTTAATCCTAATTCTTAGTCCTTGCCTGTGAGA 481 TATGAGGTCTTACAGGAGACCTCAGAGCTCCCAGCCCTTCTCCTCCTGCTAACCCTTCTCACACCCTCAAGAGGAGTTAG 561 AAAAGAGGTCCTTGTCATTCTCACCTCTTATGGAAAATGGAATAAGAAATAATCATATCCTTTCTTCCCACCCTTCTCCT 641 GTTATTTAGGATTTCTGACAAAGCTGGCTTGAGATTGGTCACTTAGAGCCGACTGTCTCCTCTGCCTTTTGTTTTTCAGC 721 TTCAGAGACAGATCCAATATAGTCCCAGGGACCTGGGTCTCTGGGAGAGGAAGGAAGAGGGAGGGAGCAAAGAGATTGGG 801 GTATGTCCCCTGTAGTACACTCTTACCTCTTACTTCCTAGACTTTGATTTCTCCGGCAGCCCAGATGTTCAGTTCTCTTG 881 GCCCCTCTCTACCCCTTACTGGGATCCGGTTTTCATTTTCCGGTCCTTTTGCCATACACAGTTACAGAGATCAGTCAAAT 961 CCATACCACCACTGAGATCTCATTTATTGCCACAGATGCACAAAATAAATAACCCAAAATCACAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000376773.1 | 3UTR | UCUCUUGGCCCCUCUCUACCCCUUACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
42 hsa-miR-3940-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT118010 | BLOC1S3 | biogenesis of lysosomal organelles complex 1 subunit 3 | 2 | 6 | ||||||||
MIRT268170 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT289461 | BIRC5 | baculoviral IAP repeat containing 5 | 2 | 4 | ||||||||
MIRT409766 | HRH2 | histamine receptor H2 | 2 | 2 | ||||||||
MIRT452070 | ZNF585B | zinc finger protein 585B | 2 | 8 | ||||||||
MIRT458519 | GSG2 | histone H3 associated protein kinase | 2 | 6 | ||||||||
MIRT458657 | SGPP2 | sphingosine-1-phosphate phosphatase 2 | 2 | 2 | ||||||||
MIRT465898 | TMEM41B | transmembrane protein 41B | 2 | 2 | ||||||||
MIRT469877 | PURB | purine rich element binding protein B | 2 | 4 | ||||||||
MIRT470462 | PPP1R11 | protein phosphatase 1 regulatory inhibitor subunit 11 | 2 | 2 | ||||||||
MIRT481439 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 2 | ||||||||
MIRT482643 | RPL18A | ribosomal protein L18a | 2 | 2 | ||||||||
MIRT486034 | CYTH1 | cytohesin 1 | 2 | 2 | ||||||||
MIRT486423 | RXRA | retinoid X receptor alpha | 2 | 2 | ||||||||
MIRT490254 | MFI2 | melanotransferrin | 2 | 2 | ||||||||
MIRT491213 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 4 | ||||||||
MIRT492849 | NRGN | neurogranin | 2 | 2 | ||||||||
MIRT492995 | NAV1 | neuron navigator 1 | 2 | 2 | ||||||||
MIRT493423 | KDM6B | lysine demethylase 6B | 2 | 2 | ||||||||
MIRT495331 | MON1B | MON1 homolog B, secretory trafficking associated | 2 | 2 | ||||||||
MIRT496865 | C21orf2 | chromosome 21 open reading frame 2 | 2 | 2 | ||||||||
MIRT498435 | EHD4 | EH domain containing 4 | 2 | 2 | ||||||||
MIRT514977 | CCBE1 | collagen and calcium binding EGF domains 1 | 2 | 2 | ||||||||
MIRT525668 | KXD1 | KxDL motif containing 1 | 2 | 2 | ||||||||
MIRT564349 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT565241 | TRAF6 | TNF receptor associated factor 6 | 2 | 2 | ||||||||
MIRT573209 | C12orf49 | chromosome 12 open reading frame 49 | 2 | 2 | ||||||||
MIRT635215 | ZNF286A | zinc finger protein 286A | 2 | 4 | ||||||||
MIRT638282 | SH2B3 | SH2B adaptor protein 3 | 2 | 2 | ||||||||
MIRT650230 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 2 | ||||||||
MIRT665256 | ZNF286B | zinc finger protein 286B | 2 | 2 | ||||||||
MIRT665833 | TIMELESS | timeless circadian clock | 2 | 2 | ||||||||
MIRT666891 | POLA2 | DNA polymerase alpha 2, accessory subunit | 2 | 2 | ||||||||
MIRT667161 | NRXN3 | neurexin 3 | 2 | 2 | ||||||||
MIRT679853 | GPR75 | G protein-coupled receptor 75 | 2 | 2 | ||||||||
MIRT680747 | CA5B | carbonic anhydrase 5B | 2 | 2 | ||||||||
MIRT682071 | QPCTL | glutaminyl-peptide cyclotransferase like | 2 | 2 | ||||||||
MIRT695801 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | 2 | 2 | ||||||||
MIRT705465 | ATG9A | autophagy related 9A | 2 | 2 | ||||||||
MIRT714270 | LTBP2 | latent transforming growth factor beta binding protein 2 | 2 | 2 | ||||||||
MIRT716392 | NPAS1 | neuronal PAS domain protein 1 | 2 | 2 | ||||||||
MIRT718443 | RAB11B | RAB11B, member RAS oncogene family | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|